Magdeburg, Germany
InLine-Med GmbH is a MedTech Company that specializes in providing a GPS solution for interventional radiology to ensure safe and precise needle placement in cancer diagnosis and treatment. The company utilizes artificial intelligence, innovative guiding tools, and high-quality biopsy needles to enhance efficiency, accuracy, and safety in medical procedures.
One of the primary challenges in interventional procedures is accurately placing a needle due to space constraints and the lack of easy-to-integrate assistance devices. However, InLine-Med GmbH's solution overcomes this challenge by employing artificial intelligence algorithms to translate the clinician's planning from the computer viewer to the patient, eliminating the need for expensive and complicated robotic systems. The app guides the clinician on where to place the sterilized-disposable needle guide based on their defined trajectory, reducing the need for multiple punctures, decreasing procedure time, and minimizing risks for both the patient and clinician.
The company offers a complete solution of assistance tools and biopsy needles at a price comparable to standard biopsy needles, empowering clinicians to conduct precise, intuitive, and efficient cancer diagnosis and treatment. Founded in 2019 and headquartered in Germany, InLine-Med GmbH recently secured a Seed Round investment from InLine investment on 03 August 2022, with participation from bmp Ventures, Kristin Lüdemann, and Ralf Lüdemann.
